17.73
price up icon2.01%   0.35
after-market Handel nachbörslich: 17.73
loading
Schlusskurs vom Vortag:
$17.38
Offen:
$17.37
24-Stunden-Volumen:
976.91K
Relative Volume:
0.86
Marktkapitalisierung:
$972.79M
Einnahmen:
$14.34M
Nettoeinkommen (Verlust:
$-199.00M
KGV:
-4.523
EPS:
-3.92
Netto-Cashflow:
$-183.51M
1W Leistung:
+9.04%
1M Leistung:
+28.76%
6M Leistung:
+56.49%
1J Leistung:
+227.73%
1-Tages-Spanne:
Value
$16.56
$17.79
1-Wochen-Bereich:
Value
$15.59
$17.79
52-Wochen-Spanne:
Value
$4.45
$19.18

Uniqure N V Stock (QURE) Company Profile

Name
Firmenname
Uniqure N V
Name
Telefon
1-339-970-7000
Name
Adresse
PAASHEUVELWEG 25A, AMSTERDAM
Name
Mitarbeiter
209
Name
Twitter
@uniQure_NV
Name
Nächster Verdiensttermin
2024-07-30
Name
Neueste SEC-Einreichungen
Name
QURE's Discussions on Twitter

Vergleichen Sie QURE mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
QURE
Uniqure N V
17.73 933.29M 14.34M -199.00M -183.51M -3.92
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.93 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.54 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.22 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
733.66 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.73 36.53B 3.81B -644.79M -669.77M -6.24

Uniqure N V Stock (QURE) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-08-14 Hochstufung Mizuho Neutral → Outperform
2025-04-01 Fortgesetzt Chardan Capital Markets Buy
2024-12-10 Hochstufung Raymond James Outperform → Strong Buy
2024-10-10 Fortgesetzt Raymond James Outperform
2024-02-29 Herabstufung Goldman Buy → Neutral
2023-12-19 Herabstufung Mizuho Buy → Neutral
2022-03-17 Hochstufung UBS Neutral → Buy
2021-06-15 Eingeleitet BTIG Research Buy
2021-05-21 Eingeleitet UBS Neutral
2021-04-26 Fortgesetzt Credit Suisse Outperform
2021-04-01 Hochstufung Mizuho Neutral → Buy
2021-01-07 Hochstufung Guggenheim Neutral → Buy
2020-11-24 Eingeleitet H.C. Wainwright Buy
2020-11-11 Eingeleitet Berenberg Buy
2020-11-09 Eingeleitet Jefferies Buy
2020-11-04 Eingeleitet Cantor Fitzgerald Overweight
2020-10-23 Eingeleitet RBC Capital Mkts Outperform
2020-08-25 Eingeleitet Raymond James Strong Buy
2020-07-31 Hochstufung Robert W. Baird Neutral → Outperform
2020-06-25 Herabstufung Mizuho Buy → Neutral
2020-06-25 Herabstufung Robert W. Baird Outperform → Neutral
2020-06-25 Herabstufung Wells Fargo Overweight → Equal Weight
2019-12-03 Eingeleitet Cowen Outperform
2019-12-03 Eingeleitet Goldman Buy
2019-11-05 Eingeleitet Credit Suisse Outperform
2019-10-11 Eingeleitet Stifel Buy
2019-09-25 Eingeleitet Bernstein Outperform
2019-09-12 Eingeleitet Mizuho Buy
2019-07-30 Herabstufung Guggenheim Buy → Neutral
2019-07-08 Bestätigt Cantor Fitzgerald Overweight
2019-04-12 Eingeleitet Piper Jaffray Overweight
2019-03-29 Eingeleitet Robert W. Baird Outperform
Alle ansehen

Uniqure N V Aktie (QURE) Neueste Nachrichten

pulisher
Sep 03, 2025

Understanding uniQure N.V.’s price movementCEO Change & Weekly Momentum Picks - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Has uniQure N.V. formed a bullish divergence2025 Key Lessons & Fast Gain Stock Tips - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What does recent volatility data suggest for uniQure N.V.Trade Entry Summary & Community Verified Watchlist Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What indicators show strength in uniQure N.V.2025 Technical Patterns & Safe Capital Preservation Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Ranking uniQure N.V. among high performing stocks via tools2025 Key Lessons & Consistent Growth Equity Picks - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Long term hold vs stop loss in uniQure N.V.Market Performance Report & Verified Short-Term Trading Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Price action breakdown for uniQure N.V.2025 Trade Ideas & Weekly Breakout Opportunity Watchlist - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Can uniQure N.V. rally from current levelsJuly 2025 Price Swings & Accurate Buy Signal Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Using economic indicators to assess uniQure N.V. potential2025 Historical Comparison & Smart Investment Allocation Tips - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is now a turning point for uniQure N.V.Weekly Risk Report & Free Risk Controlled Daily Trade Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Can uniQure N.V. outperform in the next rallyJuly 2025 Update & Long-Term Safe Investment Ideas - khodrobank.com

Sep 03, 2025
pulisher
Sep 02, 2025

uniQure N.V. stock chart pattern explained2025 Price Momentum & Consistent Growth Stock Picks - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Using data tools to time your uniQure N.V. exitPortfolio Profit Report & Weekly Stock Performance Updates - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Chart based analysis of uniQure N.V. trendsProduct Launch & AI Powered Market Entry Ideas - Newser

Sep 02, 2025
pulisher
Sep 01, 2025

What technical models suggest about uniQure N.V.’s comebackRate Cut & Community Trade Idea Sharing - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Comparing uniQure N.V. in custom built stock radarsAnalyst Downgrade & Long-Term Safe Investment Plans - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Published on: 2025-09-01 20:24:08 - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Technical analysis overview for uniQure N.V. stockPortfolio Return Report & Precise Trade Entry Recommendations - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

What’s the outlook for uniQure N.V.’s sectorJuly 2025 Momentum & Verified Stock Trade Ideas - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Can uniQure N.V. hit a new high this month2025 Bull vs Bear & Growth Focused Entry Point Reports - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Building trade automation scripts for uniQure N.V.2025 Price Action Summary & Long-Term Growth Plans - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Growth Value: Does uniQure N.V. have pricing power2025 Momentum Check & Short-Term Swing Trade Alerts - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Should you hold or exit uniQure N.V. nowWeekly Investment Summary & Accurate Buy Signal Alerts - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Institutional investors are uniQure N.V.'s (NASDAQ:QURE) biggest bettors and were rewarded after last week's US$53m market cap gain - simplywall.st

Sep 01, 2025
pulisher
Sep 01, 2025

Using data filters to optimize entry into uniQure N.V.Analyst Downgrade & Entry and Exit Point Strategies - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

uniQure N.V. stock trend outlook and recovery path2025 Price Targets & Smart Swing Trading Techniques - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Tick level data insight on uniQure N.V. volatilityMarket Activity Report & Smart Swing Trading Techniques - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Will a bounce in uniQure N.V. offer an exitTreasury Yields & Advanced Swing Trade Entry Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

How to escape a deep drawdown in uniQure N.V.Market Growth Report & Free Long-Term Investment Growth Plans - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Should you wait for a breakout in uniQure N.V.Weekly Profit Report & AI Based Buy and Sell Signals - Newser

Aug 31, 2025
pulisher
Aug 30, 2025

Relative strength of uniQure N.V. in sector analysisWall Street Watch & Long-Term Investment Growth Plans - Newser

Aug 30, 2025

Finanzdaten der Uniqure N V-Aktie (QURE)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Uniqure N V-Aktie (QURE) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Springhorn Jeremy P.
Director
Jun 20 '25
Sale
14.45
2,112
30,518
37,694
POST LEONARD E
Director
Jun 20 '25
Sale
14.45
2,112
30,518
29,937
Kaye Jack
Director
Jun 20 '25
Sale
14.45
2,112
30,518
20,439
Jacques Rachelle Suzanne
Director
Jun 20 '25
Sale
14.45
2,112
30,518
28,346
Gut Robert
Director
Jun 20 '25
Sale
14.45
3,336
48,205
56,879
Balachandran Madhavan
Director
Jun 20 '25
Sale
14.45
2,112
30,518
37,697
Meek David D.
Director
Jun 20 '25
Sale
14.45
2,112
30,518
34,190
Potts Jeannette
Chief Legal Officer
Jun 16 '25
Sale
15.14
4,670
70,704
115,073
Kapusta Matthew C
CEO, Managing Director
Mar 04 '25
Sale
10.29
28,341
291,629
651,454
Abi-Saab Walid
Chief Medical Officer
Mar 04 '25
Sale
10.29
1,350
13,891
151,903
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Kapitalisierung:     |  Volumen (24h):